Blog
RSS FeedPosted by Michael Wonder on 16 Jan 2017
Tiny ASX listed pharma popular with Trump team
16 January 2017 - A small Australian-listed pharmaceutical company is raising eyebrows in Washington DC and with the US media ...
Posted by Michael Wonder on 12 Jan 2017
Pharma company executives debate drug pricing increases
12 January 2017 - Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to ...
Posted by Michael Wonder on 12 Jan 2017
What Trump gets wrong about drug companies
12 January 2017 - President-elect Donald Trump was hardly timid in declaring Wednesday that drug companies are “getting away with ...
Posted by Michael Wonder on 12 Jan 2017
Donald Trump says pharmaceutical industry 'getting away with murder', stocks slide
12 January 2017 - US President-elect Donald Trump said pharmaceutical companies were "getting away with murder" in what they charged ...
Posted by Michael Wonder on 12 Jan 2017
Biopharma needs to stop getting blindsided by Donald Trump
11 January 2017 - The day after Donald Trump won the US presidential election, pharma and biotech investors seemed to ...
Posted by Michael Wonder on 12 Jan 2017
MTPConnect reveals final 10-year plan for medical technology, biotechnology and pharmaceutical sector
12 January 2017 - MTPConnect - the Medical Technologies and Pharmaceuticals Industry Growth Centre - today launched the final Sector ...
Posted by Michael Wonder on 12 Jan 2017
Aussie pharmaceuticals whacked by Donald Trump
12 January 2017 - Australian health stocks took an early hit on the local market following US president elect Donald ...
Posted by Michael Wonder on 11 Jan 2017
National Cancer Institute and drug companies aim to speed up clinical trials
11 January 2017 - The National Cancer Institute launched an effort Wednesday to speed up clinical trials by getting researchers ...
Posted by Michael Wonder on 09 Jan 2017
Seeking thought leaders: new advisory council to Medicines Australia
9 January 2017 - The future focussed Advisory Council will provide the Board with strategic advice on trends and issues ...
Posted by Michael Wonder on 08 Jan 2017
Don’t thank big government for medical breakthroughs
5 January 2017 - New cures come from private research, not cash dumped into the National Institutes of Health. ...
Posted by Michael Wonder on 05 Jan 2017
New “21st Century Cures” legislation: speed and ease versus science
5 January 2017 - The 21st Century Cures Act was signed into law in December 2016. Praised by its advocates as ...
Posted by Michael Wonder on 04 Jan 2017
The changing face of clinical trials: the large pharmaceutical company perspective
4 January 2017 - Large pharmaceutical companies conduct clinical trials to evaluate efficacy and identify safety issues for candidate drugs as ...
Posted by Michael Wonder on 04 Jan 2017
Drop in FDA approvals (and new administration) rekindles fears for the future of pharma
3 December 2016 - 2016 was a bummer! After years of rising FDA approvals that swelled to an all-time high of ...
Posted by Michael Wonder on 20 Dec 2016
Productivity Commission’s report recommendations would hurt Australian innovation and delay access to breakthrough medicines
20 December 2016 - The Productivity Commission report recommendations, if adopted, would put local jobs, investment and Australian patients’ early ...
Posted by Michael Wonder on 18 Dec 2016
Tailored scientific advice to support step-by-step development of new biosimilars
16 December 2016 - Pilot project to commence in February 2017. ...